Terms: = Thyroid cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Treatment
91 results:
1. An ultrasound-based nomogram for predicting axillary node pathologic complete response after neoadjuvant chemotherapy in breast cancer: Modeling and external validation.
Zheng Q; Yan H; He Y; Wang J; Zhang N; Huo L; Liu Y; Wang L; Xu L; Fan Z
Cancer; 2024 Apr; 130(S8):1513-1523. PubMed ID: 38427584
[TBL] [Abstract] [Full Text] [Related]
2. Patterns of treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary thyroid Carcinoma.
Hadoux J; Al Ghuzlan A; Lamartina L; Bani MA; Moog S; Attard M; Scoazec JY; Hartl D; Aldea M; Friboulet L; Jules-Clement G; Italiano A; Besse B; Lacroix L; Baudin E
JCO Precis Oncol; 2023 Sep; 7():e2300053. PubMed ID: 38127829
[TBL] [Abstract] [Full Text] [Related]
3. Characterization of the thyroid cancer Genomic Landscape by Plasma-Based Circulating Tumor DNA Next-Generation Sequencing.
Tarasova VD; Tsai J; Masannat J; Hernandez Prera JC; Hallanger Johnson J; Veloski C; Agosto Salgado S; McIver B; Drusbosky LM; Chung CH
Thyroid; 2024 Feb; 34(2):197-205. PubMed ID: 37962267
[No Abstract] [Full Text] [Related]
4. Therapeutic inhibition of ATR in differentiated thyroid cancer.
Lin SF; Lee YY; Wu MH; Lu YL; Yeh CN; Chen WY; Chou TC; Wong RJ
Endocr Relat Cancer; 2023 Dec; 30(12):. PubMed ID: 37902083
[TBL] [Abstract] [Full Text] [Related]
5. Integrated analysis of tumor microenvironment features to establish a diagnostic model for papillary thyroid cancer using bulk and single-cell RNA sequencing technology.
Wang Y; Song W; Li Y; Liu Z; Zhao K; Jia L; Wang X; Jiang R; Tian Y; He X
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16837-16850. PubMed ID: 37733241
[TBL] [Abstract] [Full Text] [Related]
6. Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study.
Bersanelli M; Cortellini A; Leonetti A; Parisi A; Tiseo M; Bordi P; Michiara M; Bui S; Cosenza A; Ferri L; Giudice GC; Testi I; Rapacchi E; Camisa R; Vincenzi B; Caruso G; Rauti AN; Arturi F; Tucci M; Santo V; Ricozzi V; Burtet V; Sgargi P; Todeschini R; Zustovich F; Stucci LS; Santini D; Buti S
Cancer Immunol Immunother; 2023 Nov; 72(11):3707-3716. PubMed ID: 37638980
[TBL] [Abstract] [Full Text] [Related]
7. Nanotechnological Advancements for the Theranostic Intervention in Anaplastic thyroid cancer: Current Perspectives and Future Direction.
Uppalapati SS; Guha L; Kumar H; Mandoli A
Curr Cancer Drug Targets; 2024; 24(3):245-270. PubMed ID: 37424349
[TBL] [Abstract] [Full Text] [Related]
8. Influence factors and nomogram for volume reduction rate in benign thyroid nodule after thermal ablation.
Cao S; Wang L; Wei Y; Zhao Z; Wu J; Yu M
Int J Hyperthermia; 2023; 40(1):2220562. PubMed ID: 37344375
[TBL] [Abstract] [Full Text] [Related]
9. Inflammatory myofibroblastic tumor of the thyroid gland.
Zhang Y; Liu J
Front Endocrinol (Lausanne); 2023; 14():1156117. PubMed ID: 37255972
[TBL] [Abstract] [Full Text] [Related]
10. Tumor PD-L1 expression and molecular profiling are not associated with immune checkpoint inhibitor-induced thyroid dysfunction in advanced NSCLC patients.
Horesh A; Pollack R; Nechushtan H; Dresner-Pollak R; Neuman T
Pathol Oncol Res; 2023; 29():1610951. PubMed ID: 37139142
[No Abstract] [Full Text] [Related]
11. [Duodenal bleeding due to metastasis from lung adenocarcinoma controlled by radiotherapy: A case report and literature review].
Severin S; Terrones Munoz V; Meert N; Peche R
Rev Mal Respir; 2023 Apr; 40(4):359-365. PubMed ID: 36868976
[TBL] [Abstract] [Full Text] [Related]
12. [Effects of adjuvant trastuzumab on long-term survival of T1N0M0 stage human epidermal growth factor receptor 2 positive breast cancer: a real-world study].
Sun TH; Lu ZN; Song HT; Sun G
Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):101-107. PubMed ID: 36709127
[No Abstract] [Full Text] [Related]
13. Efficacy of Immunotherapy in Second-Line treatment of
Knetki-Wróblewska M; Tabor S; Płużański A; Lewandowska Z; Tysarowski A; Pawlik H; Kowalski DM; Krzakowski M
Curr Oncol; 2022 Dec; 30(1):462-475. PubMed ID: 36661686
[TBL] [Abstract] [Full Text] [Related]
14. Inhibition of alk-Signaling Overcomes STRN-alk-Induced Downregulation of the Sodium Iodine Symporter and Restores Radioiodine Uptake in thyroid Cells.
Nikitski AV; Condello V; Divakaran SS; Nikiforov YE
Thyroid; 2023 Apr; 33(4):464-473. PubMed ID: 36585857
[No Abstract] [Full Text] [Related]
15. NR4A3 fusions characterize a distinctive peritoneal mesothelial neoplasm of uncertain biological potential with pure adenomatoid/microcystic morphology.
Agaimy A; Brcic L; Briski LM; Hung YP; Michal M; Michal M; Nielsen GP; Stoehr R; Rosenberg AE
Genes Chromosomes Cancer; 2023 May; 62(5):256-266. PubMed ID: 36524687
[TBL] [Abstract] [Full Text] [Related]
16. Guidelines on the Use of Systemic Therapy in Patients with Advanced thyroid cancer.
Wadsley J; Beasley M; Garcez K; Hoy S; Newbold K; Boelaert K
Clin Oncol (R Coll Radiol); 2023 Jan; 35(1):57-64. PubMed ID: 36336580
[TBL] [Abstract] [Full Text] [Related]
17. Clinicopathological significance of major fusion oncogenes in papillary thyroid carcinoma: An individual patient data meta-analysis.
Vuong HG; Le HT; Le TTB; Le T; Hassell L; Kakudo K
Pathol Res Pract; 2022 Dec; 240():154180. PubMed ID: 36306725
[TBL] [Abstract] [Full Text] [Related]
18. A semiquantitative study of the optimal whole-body imaging time after
Liu S; Zuo R; Yang T; Pang H; Wang Z
Front Endocrinol (Lausanne); 2022; 13():955387. PubMed ID: 36093082
[TBL] [Abstract] [Full Text] [Related]
19. Emerging drugs for the treatment of radioactive iodine refractory papillary thyroid cancer.
Leboulleux S; Lamartina L; Hadoux J; Baudin E; Schlumberger M
Expert Opin Investig Drugs; 2022 Jul; 31(7):669-679. PubMed ID: 35522027
[TBL] [Abstract] [Full Text] [Related]
20. Clinicopathological and Molecular Features of Secondary cancer (Metastasis) to the thyroid and Advances in Management.
Nguyen M; He G; Lam AK
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328664
[TBL] [Abstract] [Full Text] [Related]
[Next]
